Filippo Piffaretti earned his degree in micro technical engineering and a PhD in laser-tissue interaction and spectroscopy from the Swiss Federal Institute of Technology Lausanne (EPFL) in 2010. Since 2012, he has been leading Oculox Technologies SA. He focuses on developing, prototyping, clinically validating, certifying, manufacturing, and fostering market success of medical devices related to ophthalmology. Piffaretti is involved in engineering and clinical research in various areas, including medical device and related technology development, laser-tissue interactions, prophylaxis and light combination therapy for early AMD pathological stages, measures to stop myopia progression, pupillometry, fundamental science research in cells and tissue response to low-level-light stimulation, and diagnostics for chronic-degenerative pathologies such as Retinitis Pigmentosa, AMD, Glaucoma, Alzheimer's disease, melanopsins & ipRGC.